Splenic hematopoiesis after granulocyte-colony stimulating factor therapy in a lupus patient
Wai‐Chiu Tsoi(Chinese University of Hong Kong), Chi‐Shun Feng(Prince of Wales Hospital), Ka‐Fai To(Chinese University of Hong Kong)
American Journal of Hematology
December 1, 1996
Cited by 2
Related Papers
Biomarker Analyses and Final Overall Survival Results From a Phase III, Randomized, Open-Label, First-Line Study of Gefitinib Versus Carboplatin/Paclitaxel in Clinically Selected Patients With Advanced Non–Small-Cell Lung Cancer in Asia (IPASS)
|Journal of Clinical Oncology|2011|1.6k
Antitumor Activity of Nivolumab in Recurrent and Metastatic Nasopharyngeal Carcinoma: An International, Multicenter Study of the Mayo Clinic Phase 2 Consortium (NCI-9742)
|Journal of Clinical Oncology|2018|473
MicroRNA-223 Is Commonly Repressed in Hepatocellular Carcinoma and Potentiates Expression of Stathmin1
|Gastroenterology|2008|424
miR-130b Promotes CD133+ Liver Tumor-Initiating Cell Growth and Self-Renewal via Tumor Protein 53-Induced Nuclear Protein 1
|Cell stem cell|2010|386
Exome and genome sequencing of nasopharynx cancer identifies NF-κB pathway activating mutations
|Nature Communications|2017|336